HONG KONG, Feb. 24, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced that its partner on ivonescimab, Summit Therapeutics Inc. (NASDAQ: SMMT) has entered into a clinical trial collaboration with Pfizer Inc. (NYSE: PFE) to evaluate ivonescimab, a novel,...
Read More Details
Finally We wish PressBee provided you with enough information of ( Akeso Highlights Collaboration Between Its Partner Summit Therapeutics and Pfizer to Explore Ivonescimab in Combination with Pfizer's ADCs )
Also on site :
- Uno de los médicos acusados de suministrar ketamina a Matthew Perry acepta declararse culpable, según muestra el documento
- ‘Like the world has forgotten us:’ As Iran-Israel conflict escalates, Gazans fear their suffering will become invisible
- In Q1 2025, enterprise SaaS M&A deal count hit 210, according to PitchBook